Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Curr Microbiol ; 81(2): 70, 2024 Jan 19.
Artículo en Inglés | MEDLINE | ID: mdl-38240847

RESUMEN

Optimal management for patients with bacterial ventriculitis/meningitis due to Gram-negative rods (GNRs) has yet to be well investigated. We assessed the clinical characteristics, treatment, and outcomes of patients with a positive cerebrospinal fluid (CSF) culture for GNRs. We conducted a retrospective cohort study of all patients with a positive CSF culture within the Veterans Health Administration (VHA) system during 2003-2020. Clinical and microbiological characteristics between the true meningitis and contamination groups were compared. Of the 5919 patients with positive CSF cultures among 125 nationwide VHA acute-care hospitals, 297 (5.0%) were positive for GNRs. Among 262 patients analyzed, 156 (59.5%) were assessed as patients with true meningitis, and 106 (40.5%) were assessed as patients with contaminated CSF cultures. Patients with true meningitis had a significantly higher CSF protein (median 168 vs 57 mg/dL, p < 0.001), CSF white blood cell count (median 525 vs 3/µL, p = 0.008) and percentage of neutrophils in CSF (median 88 vs 4%, p < 0.001). Enterobacterales were more common in the true meningitis group, while unidentified GNR or polymicrobial CSF cultures were more common in the contamination group. The all-cause 90-day mortality was 25.0% (39/156) in patients with true meningitis and 10.4% (11/106) in those with contaminated CSF cultures. None of the 11 patients with contaminated CSF cultures who died were considered due to missed meningitis. More than 40% of patients with a positive CSF culture with GNR did not receive treatment without negative consequences. Careful clinical judgment is required to decide whether to treat such patients.


Asunto(s)
Meningitis Bacterianas , Veteranos , Humanos , Estudios Retrospectivos , Salud de los Veteranos , Bacterias , Meningitis Bacterianas/tratamiento farmacológico , Meningitis Bacterianas/líquido cefalorraquídeo , Meningitis Bacterianas/microbiología , Bacterias Gramnegativas , Hospitales
4.
Vaccine ; 40(32): 4654-4662, 2022 07 30.
Artículo en Inglés | MEDLINE | ID: mdl-35750541

RESUMEN

BACKGROUND: There is a long history in Japan of public concerns about vaccine adverse events. Few studies have assessed how mobile messenger apps affect COVID-19 vaccine hesitancy. METHODS: Corowa-kun, a free chatbot, was created on February 6, 2021 in LINE, the most popular messenger app in Japan. Corowa-kun provides instant, automated answers to 70 frequently asked COVID-19 vaccine questions. A cross-sectional survey with 21 questions was performed within Corowa-kun during April 5-12, 2021. RESULTS: A total of 59,676 persons used Corowa-kun during February-April 2021. Of them, 10,192 users (17%) participated in the survey. Median age was 55 years (range 16-97), and most were female (74%). COVID-19 vaccine hesitancy reported by survey respondents decreased from 41% to 20% after using Corowa-kun. Of the 20% who remained hesitant, 16% (1,675) were unsure, and 4% (364) did not intend to be vaccinated. Factors associated with vaccine hesitancy were: age 16-34 (odds ratio [OR] = 3.7; 95% confidential interval [CI]: 3.0-4.6, compared to age ≥ 65), female sex (OR = 2.4; Cl: 2.1-2.8), and history of a previous vaccine side-effect (OR = 2.5; Cl: 2.2-2.9). Being a physician (OR = 0.2; Cl: 0.1-0.4) and having received a flu vaccine the prior season (OR = 0.4; Cl: 0.3-0.4) were protective. CONCLUSIONS: A substantial number of people used the chabot in a short period. Mobile messenger apps could be leveraged to provide accurate vaccine information and to investigate vaccine intention and risk factors for vaccine hesitancy.


Asunto(s)
COVID-19 , Aplicaciones Móviles , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , COVID-19/prevención & control , Vacunas contra la COVID-19 , Estudios Transversales , Femenino , Humanos , Japón , Masculino , Persona de Mediana Edad , Padres , Aceptación de la Atención de Salud , Vacunación , Adulto Joven
6.
Am J Respir Crit Care Med ; 179(4): 279-87, 2009 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-19011155

RESUMEN

RATIONALE: Werner's syndrome is a genetic disorder that causes premature aging due to loss-of-function mutations in a gene encoding a member of the RecQ helicase family. Both Werner's syndrome and cigarette smoking accelerate aging. No studies have examined the effect of cigarette smoke on Werner's syndrome protein. OBJECTIVES: To investigate the role of Werner's syndrome protein in cigarette smoke-induced cellular senescence. METHODS: Cellular senescence and amounts of Werner's syndrome protein were measured in fibroblasts isolated from patients with emphysema and compared with age-matched nonsmokers. The in vitro effects of cigarette smoke on amounts of Werner's syndrome protein, function, and senescence were also evaluated in primary human lung fibroblasts and epithelial cells. MEASUREMENTS AND MAIN RESULTS: Cultured lung fibroblasts isolated from patients with emphysema exhibited a senescent phenotype accompanied by a decrease in Werner's syndrome protein. Cigarette smoke extract decreased Werner's syndrome protein in cultured fibroblasts and epithelial cells. Werner's syndrome protein-deficient fibroblasts were more susceptible to cigarette smoke-induced cellular senescence and cell migration impairment. In contrast, exogenous overexpression of Werner's syndrome protein attenuated the cigarette smoke effects. CONCLUSIONS: Cigarette smoke induces cellular senescence and cell migration impairment via Werner's syndrome protein down-regulation. Rescue of Werner's syndrome protein down-regulation may represent a potential therapeutic target for smoking-related diseases.


Asunto(s)
Senescencia Celular , Exodesoxirribonucleasas/metabolismo , Fibroblastos/metabolismo , RecQ Helicasas/metabolismo , Contaminación por Humo de Tabaco , Síndrome de Werner/metabolismo , Técnicas de Cultivo de Célula , Regulación hacia Abajo , Humanos , Immunoblotting/métodos , Pulmón/citología , Pulmón/metabolismo , Proteínas de Neoplasias , Proteínas Nucleares , Estrés Oxidativo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa/métodos , Ubiquitina-Proteína Ligasas , Helicasa del Síndrome de Werner
7.
Semin Pediatr Neurol ; 26: 80-82, 2018 07.
Artículo en Inglés | MEDLINE | ID: mdl-29961528

RESUMEN

We report a case of a 20-month-old girl with atypical presentation of a fairly common condition. She presented with acute onset of fever, seizures, and hemiparesis. Her cerebrospinal fluid showed total nucleated cells 10/mm3 with lymphocyte dominance. Polymerase chain reaction was negative for herpes simplex virus. Computed tomography of head showed a cerebral hemorrhage of the left frontal lobe and small subarachnoid hemorrhage in the right frontal region. Brain magnetic resonance imaging revealed multiple foci of hyperintensity in bilateral parietal lobes and right basal ganglia. She remained clinically stable without a specific therapy. Her diagnosis was made after a brain biopsy.


Asunto(s)
Encéfalo/patología , Encefalitis por Herpes Simple/diagnóstico , Fiebre/diagnóstico , Paresia/diagnóstico , Convulsiones/diagnóstico , Biopsia , Encéfalo/diagnóstico por imagen , Encéfalo/cirugía , Diagnóstico Diferencial , Encefalitis por Herpes Simple/tratamiento farmacológico , Encefalitis por Herpes Simple/patología , Femenino , Fiebre/tratamiento farmacológico , Fiebre/patología , Humanos , Lactante , Paresia/tratamiento farmacológico , Paresia/patología , Convulsiones/tratamiento farmacológico , Convulsiones/patología
9.
Diagn Microbiol Infect Dis ; 79(2): 205-8, 2014 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-24666704

RESUMEN

We performed prospective surveillance for candidemia at 14 Iowa hospitals in 2011-2012. A total of 163 episodes were analyzed. Candida albicans (n = 69 [42%]) and Candida glabrata (n = 58 [36%]) were the most common species. Antifungal resistance was uncommon; 9% of C. glabrata were fluconazole resistant, and 5% (3 isolates) were intermediate or resistant to 1 or more of the echinocandins. Molecular analyses of the fks1 and fks2 hotspots of the C. glabrata revealed no mutations except in 2 of these 3 isolates (L628R and S629P in fks1). Compared with previous surveillance performed in 1998-2001, there was a decrease in proportion of candidemia due to C. albicans (58 to 42%) and an increased proportion due to C. glabrata (20 to 36%). Further emergence of echinocandin resistance among the increasingly common species C. glabrata would complicate the management of this life-threatening infection.


Asunto(s)
Antifúngicos/farmacología , Candida/efectos de los fármacos , Candidemia/epidemiología , Candidemia/microbiología , Farmacorresistencia Fúngica , Equinocandinas/farmacología , Monitoreo Epidemiológico , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Candida/clasificación , Candida/aislamiento & purificación , Niño , Preescolar , Femenino , Fluconazol/farmacología , Proteínas Fúngicas/genética , Humanos , Lactante , Recién Nacido , Iowa/epidemiología , Masculino , Persona de Mediana Edad , Mutación , Prevalencia , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA